Novel resistin promoter polymorphisms: Association with serum resistin level in Japanese obese individuals

Hormone and Metabolic Research

Volumn 36, Issue 8, 2004, Pages 564-570

  Azuma, K ^a,b   Oguchi, S ^a   Matsubara, Y ^a   Mamizuka, T ^a   Murata, M ^a   Kikuchi, H ^a   Watanabe, K ^a   Katsukawa, F ^b   Yamazaki, H ^b   Shimada, A ^a   Saruta, T ^a  

^a School of Medicine   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Adiposity; Insulin resistance; Luciferese assay; Resistin; Serum level; Single nucleotide polymorphism

Indexed keywords

RESISTIN;

ADULT; ARTICLE; BLOOD LEVEL; BODY COMPOSITION; BODY MASS; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; JAPAN; LIPID DIET; MALE; NUCLEOTIDE SEQUENCE; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION;

ADENINE; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CYTOSINE; FEMALE; GUANINE; HORMONES, ECTOPIC; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; OBESITY; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RESISTIN; TRANSCRIPTION, GENETIC;

EID: 4544338791     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-825762     Document Type: Article

References (37)

1. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes. Nature 2001; 409: 307-312
2. Banerjee RR, Lazar MA. Resistin: molecular history and prognosis. J Mol Med 2003; 81: 218-226
3. Way JM, Gorgun CZ, Tong Q, Uysal KT, Brown KK, Harrington WW, Oliver WR Jr, Willson TM, Kliewer SA, Hotamisligil GS. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 2001; 276: 25651-26553
4. Rajala MW, Lin Y, Ranalletta M, Yang XM, Qian H, Gingerich R, Barzilai N, Scherer PE. Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-alpha in adipose tissue. Mol Endocrinol 2002; 16: 1920-1930
5. Maebuchi M, Machidori M, Urade R, Ogawa T, Moriyama T. Low resistin level in adipose tissue and serum in high-fat fed mice and genetically obese mice: development of an ELISA system for quantification of resistin. Arch Biochem Biophys 2003; 416: 164-170
6. Steppan CM, Brown EJ, Wright CM, Bhat S, Banerjee RR, Dai CY, Enders GH, Silberg DG, Wen X, Wu GD, Lazar MA. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA 2001; 98: 502-506
7. Smith SR, Bai F, Charbonneau C, Janderova L, Argyropoulos G. A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 2003; 52: 1611-1618
8. McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S. Resistin, central obesity, and type 2 diabetes. Lancet 2002; 359: 46-47
9. McTernan PG, McTernan CL, Chetty R, Jenner K, Fisher FM, Lauer MN, Crocker J, Barnett AH, Kumar S. Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab 2002; 87: 2407-2410
10. Yang RZ, Huang Q, Xu A, McLenithan JC, Eison JA, Shuldiner AR, Alkan S, Gong DW. Comparative studies of resistin expression and phylogenomics in human and mouse. Biochem Biophys Res Commun 2003; 310: 927-935
11. Nagaev I, Smith U. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun 2001; 285: 561-564
12. Fain JN, Cheema PS, Bahouth SW, Lloyd HM. Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun 2003; 300: 674-678
13. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, O'Rahilly S. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 2001; 50: 2199-2202
14. Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, Macphee CH, Smith SA. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 2003; 300: 472-476
15. Zhang J, Qin Y, Zheng X, Qiu J, Zou DJ. Serum resistin level in essential hypertension patients with different glucose tolerance. Diabet Med 2003; 20: 828-831
16. Yannakoulia M, Yiannakouris N, Bluher S, Matalas AL, Klimis-Zacas D, Mantzoros CS. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentration in healthy humans. J Clin Endocrinol Metab 2003; 88: 1730-1736
17. Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BLG, Murphy LJ. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlation with insulin resistance. Eur J Endocrinol 2003; 149: 331-335
18. Azuma K, Katsukawa F, Oguchi S, Murata M, Yamazaki H, Shimada A, Saruta T. Correlation between serum resistin level and adiposity in obese individuals. Obes Res 2003; 11: 997-1001
19. Yang J, Li M, Wu CYWang H, Xu QS, Deng JY. Reduced resistin levels in patients with type 2 diabetes mellitus. Zhonghua Yi Xue Za Zhi 2003; 83: 1471-1474
20. Fehmann HC, Heyn J. Plasma resistin levels in patients with type 1 and type 2 diabetes and in healthy controls. Horm Metab Res 2002; 34: 671-673
21. Furuhashi M, Ura N, Higashiura K, Mrakami H, Shimamoto K. Circulating resistin levels in essential hypertension. Clin Endocrinol 2003; 59: 507-510
22. Monzillo LU, Hamdy O, Horton ES, Ledbury S, Mullooly C, Jarema C, Porter S, Ovalle K, Moussa A, Mantzoros CS. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obes Res 2003; 11: 1048-1054
23. Lee JH, Chan JL, Yiannakouris N, Kontogianni M, Estrada E, Seip R, Orlova C, Mantzoros CS. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: Cross-sectional and interventional studies in normal, insulin resistant and diabetic subjects. J Clin Endocrinol Metab 2003; 88: 4848-4856
24. Kielstein JT, Becker B, Graf S, Brabant G, Haller H, Fliser D. Increased resistin blood levels are not associated with insulin resistance in patients with renal disease. Am J Kidney Dis 2003; 42: 62-66
25. Wang H, Chu WS, Hemphill C, Elbein SC. Human resistin gene: molecular scanning and evaluation of association with insulin sensitivity and type 2 diabetes in Caucasians. J Clin Endocrinol Metab 2002; 87: 2520-2524
26. Pizzuti A, Argiolas A, di Paola R, Baratta R, Rauseo A, Bozzali M, Vigneri R, Dallapiccola B, Trischitta V, Frittitta L. An ATG repeat in the 3′-untranslated region of the human resistin gene is associated with a decreased risk of insulin resistance. J Clin Endocrinol Metab 2002; 88: 4403-4406
27. Ma X, Warram J, Trischitta V, Doria A. Genetic variants at the resistin locus and risk of type 2 diabetes in Caucasians. J Clin Endocrinol Metab 2002; 87: 4407-4410
28. Tan MS, Chang SY, Chang DM, Tsai JC, Lee YJ. Association of resistin gene 3′-untranslated region +62G>A polymorphism with type 2 diabetes and hypertension in a Chinese population. J Clin Endocrinol Metab 2003; 88: 1258-1263
29. Osawa H, Onuma H, Murakami A, Ochi M, Nishimiya T, Kato K, Shimizu I, Fujii Y, Ohashi J, Makino H. Systematic search for single nucleotide polymorphisms in the resistin gene: the absence of evidence for the association of three identified single nucleotide polymorphisms with Japanese type 2 diabetes. Diabetes 2002; 51: 863-866
30. Sentinelli F, Romeo S, Arca M, Filippi E, Leonetti F, Banchieri M, di Mario U, Baroni MG. Human resistin gene, obesity, and type 2 diabetes: mutation analysis and population study. Diabetes 2002; 51: 860-862
31. Engert JC, Vohl MC, Williams SM, Lepage P, Loredo-Osti JC, Faith J, Dore C, Renaud Y, Burtt NP, Villeneuve A, Hirschhorn JN, Altshuler D, Groop LC, Despres JP, Gaudet D, Hudson TJ. 5′ flanking variants of resistin are associated with obesity. Diabetes 2002; 51: 1629-1634
32. Urbanek M, Du Y, Silander K, Collins FS, Steppan CM, Strauss JF 3rd, Dunaif A, Spielman RS, Legro RS. Variation in resistin gene promoter not associated with polycystic ovary syndrome. Diabetes 2003; 52: 214-217
33. Yeni-Komshian H, Abbasi F, Carantoni M, Reaven GM. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 2000; 23: 171-175
34. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
35. Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma AM. Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res 2002; 10: 1-5
36. Chakravarti A, Buetow KHAntonaraki SE, Waber PG, Boehm CD, Kazazian HH. Nonuniform recombination within the human beta-globin gene cluster. Am J Hum Genet 1984; 36: 1239-1258
37. Humphries S, Temple A, Lane A, Green F, Cooper J. Low plasma levels of factor VIIc and antigen are more strongly associated with the 10 base pair promoter (-323) insertion than the glutamine 353 variant. Thromb Haemost 1996; 74: 567-572